Sanofi Stock Quote 1SAN - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

93.77

Bid

88.00

Ask

94.15

Volume

1,312

93.15 Day's Range 94.17

80.75 52 Week Range 104.22

Market Cap

115.819B

Previous Close

92.46

Open

93.24

Last Trade

93.77

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

969

Shares Outstanding

1,252,640,466

Dividend Yield

4.01%

PE Ratio

21.69

Earnings Per Share (EPS)

4.31

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 92.46 €. Over the last year, Sanofi shares have traded in a share price range of 80.75 € to 104.22 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 115.82 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.69.

Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A

Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A NEJM publishes ALTUVIIIO...

Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints d’hémophilie A sévère

Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints...

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne Dupixent devient le tout premier médicament ciblé pour...

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Dupixent positive phase 3 data in children one to 11 years of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.04	-0.0426393774651	93.81	94.17	90.86	875	91.95454857	DE
4	5.76	6.54471082831	88.01	94.85	88	1151	92.09931153	DE
12	1.41	1.52663490689	92.36	94.85	86.2	969	90.98859394	DE
26	0.16	0.170921910052	93.61	94.85	84.98	870	89.90251837	DE
52	-5.23	-5.28282828283	99	104.22	80.75	814	90.0310654	DE
156	6.89	7.93047882136	86.88	106.06	76.36	1081	89.97876448	DE
260	19.14	25.646522846	74.63	106.06	68	1552	86.98939613	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 3.47 (403.77%)	133.3M
CMAXCareMax Inc	$ 5.2026 (229.28%)	89.17M
NUKKNukkleus Inc	$ 0.4576 (43.00%)	21.08M
LPSNLivePerson Inc	$ 1.315 (32.83%)	7.04M
SNOASonoma Pharmaceuticals Inc	$ 0.4007 (30.10%)	3.25M
CGBSCrown LNG Holdings Ltd	$ 0.99 (-29.79%)	2.89M
LGCBLinkage Global Inc	$ 3.6833 (-29.37%)	158.61k
SLNASelina Hospitality PLC	$ 0.0357 (-24.52%)	63.21M
PSIGPS International Group Ltd	$ 2.62 (-23.17%)	317.33k
SPECSpectaire Holdings Inc	$ 0.405 (-22.86%)	1.63M
NVDANVIDIA Corporation	$ 123.63 (4.83%)	182.94M
SQQQProShares UltraPro Short QQQ	$ 8.0569 (-4.76%)	152.06M
MIRAMIRA Pharmaceuticals Inc	$ 3.47 (403.77%)	133.3M
SERVServe Robotics Inc	$ 9.295 (23.11%)	130.98M
NCPLNetcapital Inc	$ 0.1117 (7.40%)	117.29M